利用医学委员会监管错误信息的问题

IF 0.3 4区医学 Q3 LAW

Journal of Legal Medicine Pub Date : 2024-04-22 DOI:10.1080/01947648.2024.2338057

Katherine Drabiak

引用次数: 0

摘要

一些利益相关者呼吁医学委员会对在 COVID-19 期间传播错误信息和讨论标签外药物的医生进行处罚。2022 年，加利福尼亚州通过了第 2098 号法案，该法案将...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Problem with Using Medical Boards to Regulate Misinformation

Some stakeholders called on medical boards to sanction physicians for spreading misinformation during COVID-19 and discussing off-label medications. In 2022, California passed AB 2098, which classi...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Legal Medicine Multiple-

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The Journal of Legal Medicine is the official quarterly publication of the American College of Legal Medicine (ACLM). Incorporated in 1960, the ACLM has among its objectives the fostering and encouragement of research and study in the field of legal medicine. The Journal of Legal Medicine is internationally circulated and includes articles and commentaries on topics of interest in legal medicine, health law and policy, professional liability, hospital law, food and drug law, medical legal research and education, the history of legal medicine, and a broad range of other related topics. Book review essays, featuring leading contributions to the field, are included in each issue.